Edesa Biotech, Inc. (EDSA): Total Liabilities
$1.83M
As of 2024-09-30
+6.3%
3-year compound annual growth
+31.8%
5-year compound annual growth
-8.3%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2024-09-30 | $1.83M | -0.5% | 2024-12-13, Balance as of period end |
| 2023-09-30 | $1.84M | -15.7% | 2024-12-13, Balance as of period end |
| 2022-09-30 | $2.18M | +43.1% | 2023-12-15, Balance as of period end |
| 2021-09-30 | $1.53M | -7.7% | 2022-12-16, Balance as of period end |
| 2020-09-30 | $1.65M | +258.3% | 2021-12-28, Balance as of period end |
| 2019-09-30 | $461.6K | n/a | 2020-12-07, Balance as of period end |
| No annual figure between 2015-09-30 and 2019-09-30. | |||
| 2015-09-30 | $2.38M | -45.4% | 2015-12-14, Balance as of period end |
| 2014-09-30 | $4.36M | n/a | 2015-12-14, Balance as of period end |
| 2014-08-31 | $6.77M | -36.8% | 2015-12-14, Balance as of period end |
| 2013-08-31 | $10.71M | n/a | 2014-11-21, Balance as of period end |